ASND Stock Ownership Activity

ASCENDIS PHARMA A/S - ADR 13F holders

No value investing guru has made any change to the ASCENDIS PHARMA A/S - ADR (ASND) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying ASND now?

According to the latest SEC filing(s) ASCENDIS PHARMA A/S - ADR (ASND) has not been purchased by any super investor.

To see more about who is investing in ASCENDIS PHARMA A/S - ADR (ASND), please go to the ASND ownership page.

2021 Q4 (1 result)
Stephen Mandel
-100.00%
-1,436,981
-0.94%
0.00%
Current price: $130.50 18.13% Reported price*: $159.39
2021 Q1 (1 result)
Stephen Mandel
+60.64%
+542,448
+0.25%
0.67%
Current price: $130.50 1.26% Reported price*: $128.88
2020 Q4 (1 result)
Stephen Mandel
buy
+487,520
+0.54%
0.30%
Current price: $130.50 21.75% Reported price*: $166.78
3 of 3

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.